AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0

Urigrow-D Tablet

Prescription Icon
Prescription Required

Marketer

Broadspectrum Remedies Private Limited

Salt Composition

Tamsulosin (0.4mg) + Dutasteride (0.5mg)

Overview Urigrow-D Tablet

ProstaCare Duo tablets combine two active ingredients with distinct mechanisms to manage benign prostatic hyperplasia (BPH) in adult males. This medication alleviates symptoms like urinary frequency and hesitancy. It does not prevent prostate cancer. ProstaCare Duo can be administered with or without food, but consistent daily timing is crucial. Dosage is determined by your physician. For optimal symptom control, maintain regular intake, even if feeling well. Symptom improvement may take up to four weeks; continued use is essential. Report any lack of improvement or worsening symptoms after four weeks. Common side effects include erectile dysfunction, reduced libido, chest pain, and ejaculatory problems. Consult your doctor if side effects are bothersome or persistent. Dizziness or drowsiness may occur, particularly initially. The prescribed benefits outweigh the potential risks. ProstaCare Duo is contraindicated in women and children. Inform your doctor of pre-existing conditions such as hypotension, hepatic or renal impairment, as this may influence suitability. Potential drug interactions exist; disclose all other medications. Condom use during sexual intercourse is advised if your partner is or might be pregnant. Regular blood pressure monitoring may be recommended. Alcohol consumption should be avoided due to increased dizziness risk.

Primary Ingredients of Urigrow-D Tablet

No text was provided to rewrite.

Uses of Urigrow-D Tablet

Managing benign prostatic enlargement

Major Benefits of Urigrow-D Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for Urigrow-D Tablets. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Urigrow-D Tablets can be administered with or without food, although consistent timing is recommended.

Common Side effects of Urigrow-D Tablet:

  • Impotence
  • Decreased libido
  • Ejaculation disorder
  • Orthostatic hypotension (sudden lowering of blood pressure on standing)
  • Breast enlargement in male
  • Breast tenderness in male
  • Dizziness

How to use Urigrow-D Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for Urigrow-D Tablets. Ingest the tablet whole; do not crush, chew, or break it. Urigrow-D Tablets can be administered with or without food, but consistent timing is recommended.

How Urigrow-D Tablet works:

Urigrow-D tablets contain Tamsulosin and Dutasteride, a dual-action formulation providing relief from benign prostatic hyperplasia (BPH) symptoms. Tamsulosin, an alpha-adrenergic blocker, eases urination by relaxing bladder neck and prostate muscles. Simultaneously, Dutasteride, a 5-alpha-reductase inhibitor, reduces prostate size by lowering levels of a hormone crucial for prostate growth.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent use of Urigrow-D tablets and alcohol can lead to significant sleepiness.

PregnancyPregnancyCONSULT YOUR DOCTOR

Data on Urigrow-D Tablet use in pregnancy is lacking. Seek medical advice from your physician.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Data on Urigrow-D Tablet use while breastfeeding is lacking. Seek medical advice from your physician.

DrivingDrivingUNSAFE

Taking Urigrow-D Tablets might reduce attentiveness, impair vision, or cause drowsiness and dizziness. Driving should be avoided if these effects are experienced.

KidneyKidneyCONSULT YOUR DOCTOR

Insufficient data exists regarding Urigrow-D Tablet's efficacy and safety in individuals with renal impairment. Physician consultation is recommended.

LiverLiverCAUTION

Patients with liver impairment should use Urigrow-D Tablets cautiously, potentially requiring dosage modification under medical supervision. Urigrow-D Tablets are contraindicated in those with severe hepatic dysfunction.

What if you forget to take Urigrow-D Tablet :

Should you forget a Urigrow-D Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Urigrow-D Tablet

LabelValue
Developing Habits No.
Treatment Category Urologic Care

FAQs on Urigrow-D Tablet

For optimal results, take Urigrow-D Tablets as prescribed by your doctor. Continue the full course of treatment, even if you feel better, to prevent symptom recurrence or worsening.
Dizziness is a possible side effect of Urigrow-D Tablet, which combines Tamsulosin and Dutasteride. Tamsulosin can trigger orthostatic hypotension—a sudden blood pressure drop upon standing—leading to dizziness, lightheadedness, fainting, or vertigo. Avoid operating machinery or driving if dizziness occurs; rest until symptoms subside.
Urigrow-D Tablets are contraindicated in males under 18 due to potential adverse effects on male reproductive development. The medication is also harmful for individuals with allergies to its components and for pregnant or women of childbearing age. Furthermore, pregnant women should avoid handling Urigrow-D Tablets to prevent potential fetal harm from dermal absorption.
Use Urigrow-D tablets only as prescribed by your doctor. Take each dose as directed, and report any bothersome side effects.
No, only take Urigrow-D tablets as directed. Exceeding the recommended dose increases the risk of side effects. Always follow your doctor's instructions for dosage and treatment duration.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication; ensure it's inaccessible to children, pets, and others.
Urigrow-D Tablet use may sometimes cause retrograde ejaculation (semen entering the bladder instead of exiting the body) or ejaculation failure (decreased or absent ejaculate). These side effects are generally benign and more frequent with higher doses.
Urigrow-D Tablets may cause priapism, a serious but uncommon side effect characterized by a painful, persistent erection. Untreated priapism can result in permanent impotence.
Urigrow-D Tablet may cause floppy iris syndrome, a condition where the iris muscles become weak, causing unexpected pupil constriction during cataract surgery. This constriction limits the surgeon's view, potentially affecting surgical outcomes. Tell your ophthalmologist if you are currently taking, or have taken within the past 9 months, Urigrow-D.
Managing prostate symptoms often involves simple lifestyle adjustments. Urinate promptly when you feel the urge, but avoid straining. Limit fluids, particularly alcohol and caffeine, in the hours before sleep or outings. Furthermore, steer clear of medications, such as some cold and cough remedies, known to exacerbate urinary issues.
Urigrow-D Tablet
225
MRP 260
13% off